Search / Trial NCT06612450

Turbinate Volume Reduction Under Local Anesthesia: Randomized Clinical Trial; Our Experience

Launched by KAFRELSHEIKH UNIVERSITY · Sep 24, 2024

Trial Information

Current as of October 07, 2024

Completed

Keywords

Turbinate Hypertrophy Coblation Radiofrequency Nasal Obstruction

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients with the following criteria were eligible for inclusion:
  • 1. Age group: 18-60 years old.
  • 2. Patients complaining of chronic nasal obstruction because of bilateral (HIT) diagnosed by our former protocol refractory to medical treatment for at least three months.
  • 3. Evident (HIT) on the CT nose and paranasal sinuses with mainly soft tissue component hypertrophy with or without minimal septal deviation without any other cause for the obstruction.
  • 4. Patients who are unfit for general anesthesia
  • Exclusion Criteria:
  • * All Patients with:
  • Marked septal deviation or Concha Bullosa, Nasal polyps, Sinonasal Tumors, Any previous nasal surgeries or radiotherapy, Chronic sinusitis or Cystic Fibrosis, Pregnancy, Patients with severe bleeding tendency, coagulopathy disorder, and Patients who refuse participation in this study were excluded from our study

About Kafrelsheikh University

Kafrelsheikh University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that contribute to the enhancement of healthcare practices and patient outcomes. With a strong emphasis on interdisciplinary collaboration, the university harnesses its diverse expertise in medical sciences, engineering, and technology to conduct rigorous clinical studies. Kafrelsheikh University aims to foster innovation in clinical research, ensuring compliance with ethical standards and regulatory requirements, while actively engaging in community health initiatives to address pressing health challenges. Through its commitment to excellence, the university seeks to develop evidence-based solutions that improve health and well-being at both local and global levels.

Locations

Kafr El Sheikh, , Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0